These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1062 related articles for article (PubMed ID: 16341265)

  • 1. CCR2 modulates inflammatory and metabolic effects of high-fat feeding.
    Weisberg SP; Hunter D; Huber R; Lemieux J; Slaymaker S; Vaddi K; Charo I; Leibel RL; Ferrante AW
    J Clin Invest; 2006 Jan; 116(1):115-24. PubMed ID: 16341265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflamed fat: what starts the fire?
    Neels JG; Olefsky JM
    J Clin Invest; 2006 Jan; 116(1):33-5. PubMed ID: 16395402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An increase in the circulating concentration of monocyte chemoattractant protein-1 elicits systemic insulin resistance irrespective of adipose tissue inflammation in mice.
    Tateya S; Tamori Y; Kawaguchi T; Kanda H; Kasuga M
    Endocrinology; 2010 Mar; 151(3):971-9. PubMed ID: 20056828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Macrophages, inflammation, adipose tissue, obesity and insulin resistance].
    Bastarrachea RA; López-Alvarenga JC; Bolado-García VE; Téllez-Mendoza J; Laviada-Molina H; Comuzzie AG
    Gac Med Mex; 2007; 143(6):505-12. PubMed ID: 18269082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diet induction of monocyte chemoattractant protein-1 and its impact on obesity.
    Chen A; Mumick S; Zhang C; Lamb J; Dai H; Weingarth D; Mudgett J; Chen H; MacNeil DJ; Reitman ML; Qian S
    Obes Res; 2005 Aug; 13(8):1311-20. PubMed ID: 16129712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic steatosis.
    Finucane OM; Reynolds CM; McGillicuddy FC; Harford KA; Morrison M; Baugh J; Roche HM
    PLoS One; 2014; 9(11):e113369. PubMed ID: 25412423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of Lactobacillus gasseri SBT2055 suppresses macrophage infiltration into adipose tissue in diet-induced obese mice.
    Ukibe K; Miyoshi M; Kadooka Y
    Br J Nutr; 2015 Oct; 114(8):1180-7. PubMed ID: 26299683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic Modulation of Inflammatory but not Metabolic Effects of High-Fat Feeding by CCR2 and CX3CR1.
    Zhang H; Hinkle CC; O'Neill SM; Shi J; Caughey J; Lynch E; Lynch G; Gerelus M; Tsai ASD; Shah R; Ferguson JF; Ahima RS; Reilly MP
    Obesity (Silver Spring); 2017 Aug; 25(8):1410-1420. PubMed ID: 28650582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in adiponectin and inflammatory genes in response to hormonal imbalances in female mice and exacerbation of depot selective visceral adiposity by high-fat diet: implications for insulin resistance.
    Zhang H; Chen X; Aravindakshan J; Sairam MR
    Endocrinology; 2007 Dec; 148(12):5667-79. PubMed ID: 17717050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual CCR2/5 Antagonist Attenuates Obesity-Induced Insulin Resistance by Regulating Macrophage Recruitment and M1/M2 Status.
    Huh JH; Kim HM; Lee ES; Kwon MH; Lee BR; Ko HJ; Chung CH
    Obesity (Silver Spring); 2018 Feb; 26(2):378-386. PubMed ID: 29280303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity.
    Lumeng CN; Deyoung SM; Bodzin JL; Saltiel AR
    Diabetes; 2007 Jan; 56(1):16-23. PubMed ID: 17192460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
    Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
    Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40L deficiency ameliorates adipose tissue inflammation and metabolic manifestations of obesity in mice.
    Poggi M; Engel D; Christ A; Beckers L; Wijnands E; Boon L; Driessen A; Cleutjens J; Weber C; Gerdes N; Lutgens E
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2251-60. PubMed ID: 21817098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-C chemokine receptor 2 inhibitor improves diet-induced development of insulin resistance and hepatic steatosis in mice.
    Tamura Y; Sugimoto M; Murayama T; Minami M; Nishikaze Y; Ariyasu H; Akamizu T; Kita T; Yokode M; Arai H
    J Atheroscler Thromb; 2010 Mar; 17(3):219-28. PubMed ID: 20179360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose tissue inflammation contributes to short-term high-fat diet-induced hepatic insulin resistance.
    Wiedemann MS; Wueest S; Item F; Schoenle EJ; Konrad D
    Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E388-95. PubMed ID: 23736545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis.
    Obstfeld AE; Sugaru E; Thearle M; Francisco AM; Gayet C; Ginsberg HN; Ables EV; Ferrante AW
    Diabetes; 2010 Apr; 59(4):916-25. PubMed ID: 20103702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice.
    Tamura Y; Sugimoto M; Murayama T; Ueda Y; Kanamori H; Ono K; Ariyasu H; Akamizu T; Kita T; Yokode M; Arai H
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2195-201. PubMed ID: 18818420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.